Filtered By:
Drug: Acetylcysteine
Management: Hospitals
This page shows you your search results in order of date.
Order by Relevance | Date
Total 35 results found since Jan 2013.
Bleomycin Overdose in a Patient with Stage II Hodgkin Lymphoma: A Case Report of a Medication Error
Br J Clin Pharmacol. 2023 Apr 14. doi: 10.1111/bcp.15744. Online ahead of print.ABSTRACTBleomycin is an antibiotic with cytotoxic properties that is commonly used in combination regimens for the treatment of Hodgkin lymphoma. The inconsistency in the dosage nomenclature of bleomycin appears universally, which increases the risk of medication errors. However, to the best of our knowledge, no such cases have been reported. Herein, we present a rare case report of a medication error caused by a bleomycin overdose. At the third cycle of chemotherapy, a 25-year-old patient with Stage II Hodgkin Lymphoma received a ten times hig...
Source: Clinical Lung Cancer - April 15, 2023 Category: Cancer & Oncology Authors: M D Zhang Jieting Xue Shuyi Chen Xiaolin M D Yang Hai Source Type: research
Comparison of Clinical Effectiveness Between Ambroxol and N-Acetylcysteine in Surgical Patients: A Retrospective Cohort Study
This study aimed to compare the clinical effectiveness between ambroxol (AMB) and N-acetylcysteine (NAC) in patients undergoing surgery. A multicenter, retrospective cohort study was conducted using deidentified medical records from hospital information system. Between July 1, 2015, and November 30, 2017, patients aged ≥18 years, who received intravenous AMB or nebulized NAC as the only expectorant therapy for >3 days during their hospitalization for thoracic, abdominal, and neurosurgery, were included in this study. The clinical outcomes were evaluated, and propensity score matching was used to adjust significant dif...
Source: The Journal of Clinical Pharmacology - October 20, 2022 Category: Drugs & Pharmacology Authors: Jiaming Bian Hong Liang Mei Zhang Source Type: research
Toxicology in the emergency department: what's new?
This article includes a care pathway that can facilitate the implementation of the Scottish and Newcastle Acetylcysteine Protocol. This article also discusses the emergency management of ingested button batteries, describes the emerging threat of novel psychoactive substances, and provides an update on new UK antidote guidelines. Further up-to-date guidance on management of clinical toxicology is available to healthcare professionals on the internet database TOXBASE.PMID:36193928 | DOI:10.12968/hmed.2022.0313
Source: British Journal of Hospital Medicine - October 4, 2022 Category: Internal Medicine Authors: Kenzo Motohashi Ruben Hk Thanacoody Source Type: research
